Loss of vinculin has been found in the development of many cancers, such as squamous carcinoma[11, 12], rhabdomyosarcoma[13] and breast cancer[14], implying that vinculin may have anti-tumour effects. This evidence concerns the gene VCL and breast carcinoma.